Skip to content

Author

S. Marupuru

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Real-world outcomes of first-line pembrolizumab monotherapy among dMMR/MSI-H advanced or recurrent endometrial cancer patients in the United States.

OBJECTIVE Describe real-world outcomes among patients with dMMR/MSI-H advanced or recurrent endometrial cancer (EC) treated with first-line (1 L) pembrolizumab monotherapy or carboplatin-paclitaxel. METHODS This retrospective cohort study used the Flatiron Health Research Database (January 1, 2013-June 30, 2025). Adu...

K. M. Mcclain, V. Prabhu, S. Marupuru et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.